Research output: Contribution to journal › Article › peer-review
A Demjaha, J M Lappin, D Stahl, M X Patel, J H MacCabe, O D Howes, Margaret Heslin, U A Reininghaus, K Donoghue, B Lomas, M Charalambides, A Onyejiaka, P Fearon, P Jones, G Doody, C Morgan, P Dazzan, R M Murray
Original language | English |
---|---|
Pages (from-to) | 1981-1989 |
Number of pages | 9 |
Journal | Psychological Medicine |
Volume | 47 |
Issue number | 11 |
Early online date | 11 Apr 2017 |
DOIs | |
Accepted/In press | 27 Jan 2017 |
E-pub ahead of print | 11 Apr 2017 |
Published | Aug 2017 |
Additional links |
Antipsychotic treatment resistance in_DEMJAHA_FirstonlineApril112017_GOLD VoR (CC-BY)
Antipsychotic_treatment_resistance_in_DEMJAHA_FirstonlineApril112017_GOLD_VoR_CC_BY_.pdf, 208 KB, application/pdf
Uploaded date:02 May 2017
Version:Final published version
Licence:CC BY
BACKGROUND: We examined longitudinally the course and predictors of treatment resistance in a large cohort of first-episode psychosis (FEP) patients from initiation of antipsychotic treatment. We hypothesized that antipsychotic treatment resistance is: (a) present at illness onset; and (b) differentially associated with clinical and demographic factors.
METHOD: The study sample comprised 323 FEP patients who were studied at first contact and at 10-year follow-up. We collated clinical information on severity of symptoms, antipsychotic medication and treatment adherence during the follow-up period to determine the presence, course and predictors of treatment resistance.
RESULTS: From the 23% of the patients, who were treatment resistant, 84% were treatment resistant from illness onset. Multivariable regression analysis revealed that diagnosis of schizophrenia, negative symptoms, younger age at onset, and longer duration of untreated psychosis predicted treatment resistance from illness onset.
CONCLUSIONS: The striking majority of treatment-resistant patients do not respond to first-line antipsychotic treatment even at time of FEP. Clinicians must be alert to this subgroup of patients and consider clozapine treatment as early as possible during the first presentation of psychosis.
King's College London - Homepage
© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454